AzTrials
AzTrials

Inclined Atrophy of the Distal MandibleGASTNCT01400321

PEERS Multicenter Osseospeed TM TX Profile Implant: German Astra Soft Tissue (GAST) Maintenance Study

An observational study of Inclined Atrophy of the Distal Mandible and Socket Like Atrophy of the Aesthetic Zone, run by Johannes Gutenberg University Mainz at 28 sites in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The open, prospective, non-controlled observational study is designed to provide information on the short-, medium- and long-term clinical performance of the Astra Tech OsseospeedTM implant surface in combination with a special implant design. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
How many people
300 participants
Where
28 sitesGermany
Study dates
Jul 2011to Jul 2014
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients with tooth loss in the aesthetic zone or in the distal mandible with socket like atrophy. The antagonists should be natural teeth or a fixed prosthesis.

Who may be able to join

  • loss of tooth aesthetic zone (a maximum of 4 implants)
  • loss of tooth at the distal mandible (distal canine) (a maximum of 4 implants)
  • presence of inclined alveolar ridge profile
  • antagonists are natural teeth or fixed prosthesis

Who cannot join

  • < 18 years
  • Tumour or irradiation
  • bisphosphonate or cortisone intake
  • Diabetes mellitus
  • Mental illness or disorder with affection of compliance
  • Consumption of > 20 cigarettes/day
Show all 10Show fewer
  • Bruxism
  • Acute Mucosal infection or illness (e.g. acute Parodontitis, Pemphigus, Lichen)
  • Relation of Crown to Implant ratio of > 1
  • No clinical primary stability of the implant after insertion

Trial locations and contacts

28 sites in 1 country.

Wilfried Wagner, MD, DMD, PHD contact

00496131177334

wilfried.wagner@unimedizin-mainz.de

Maximilian Moergel, MD, DMD contact

00496131175459

maximilian.moergel@unimedizin-mainz.de

28 sites in 1 country

Germany28 sites, 28 recruiting
  • MSc. E. Trilck

    Berlin, D-10117

    Recruiting
  • Dr.Dr. U. Schwarzott

    Berlin, D-10969

    Recruiting
  • Dr. M. Loeck

    Berlin, D-14199

    Recruiting
  • Dr. G. Körner

    Bielefeld, D-33602

    Recruiting
  • PD.Dr.Dr. E. Keese

    Braunschweig, D-38126

    Recruiting
  • Klinik für MKG Chirurgie Dortmund

    Dortmund, D-44145

    Stefan Haßfeld, MD, DMD, PHD

    Recruiting
  • Dr.Dr. V. Michalczik

    Essen, D-45259

    Recruiting
  • Dr. M.Sc. Gau

    Euskirchen, D-53879

    Recruiting
  • Dr. M. Schlee

    Forchheim, D-91301

    Recruiting
  • Dr. Borrmann

    Freiberg, D-09599

    Recruiting
  • Dr. H. Steveling

    Gernsbach, D-76593

    Recruiting
  • Dr. Dr. St. Kahnel

    Hamburg, D-20095

    Recruiting
  • Dr. U. Konter

    Hamburg, Hamburg

    Recruiting
  • K. Bothe

    Hanover, D-30169

    Recruiting
  • Klinik für MKG Chirurgie MH Hannover

    Hanover, D-30625

    Nils-Claudius Gellrich, MD, DMD, PHD

    Jan-Thomas Krause

    Recruiting
  • Dr. Ch. Mertens

    Heidelberg, 69120

    Recruiting
  • Dr. W. Knöfler

    Leipzig, D-04177

    Recruiting
  • Dr. R. Noelken

    Lindau, 88131

    Robert Noelken, DMD

    Bettina Anna Neffe

    Recruiting
  • Dr.Dr. R. Wörtche

    Lorsch, D-64653

    Recruiting
  • Department of Oral and Maxillofacial Surgery, University Mainz, Medical Center

    Mainz, Rhineland-Palatinate, 55131

    Wilfried Wagner, MD, DMD, PHD, 00496131177334 ext. q, wilfried.wagner@unimedizin-mainz.de

    Maximilian Moergel, MD, DMD, 00496131175459, maximilian.moergel@unimedizin-mainz.de

    Not yet recruiting
  • Dr. Dr. Barth

    Mannheim, D-68183

    Tilo J Barth, MD, DMD

    Recruiting
  • Dr. P. Rauch

    Melsungen, D-34212

    Recruiting
  • Dr. MMsc Dirlewanger

    Nagold, 72202

    Recruiting
  • Prof. Dr. H. Visser

    Oldenburg, 26122

    Recruiting
  • Dr.Dr. M. Kestel

    Rückersdorf, D-90607

    Recruiting
  • Dr. J. U. Wiegner

    Saalfeld, D-07318

    Recruiting
  • Dr. M. Riedl

    Stein, D-90547

    Recruiting
  • Tagesklinik für Kiefer- und Plastische Gesichtschirurgie

    Wiesbaden, 65183

    Rainer SR Buch, MD, DMD

    Christian Küttner, MD, DMD

    Recruiting

Other trials in Germany

About this study

Official title: PEERS Multicenter OsseoSpeedTM TX Profile Implant: German Astra Soft Tissue (GAST) Maintenance Study An Open, Prospective Observational Study to Evaluate Implant Stability, Marginal Bone and Soft Tissue Maintenance of the Astra Tech Dental Implant System: OsseoSpeedTM TX Profile Implant in Patients With Tooth Loss in the Aesthetic Zone or the Posterior Atrophied Mandible

The open, prospective, non-controlled observational study is designed to provide information on the short-, medium- and long-term clinical performance of the Astra Tech OsseospeedTM implant surface in combination with a special implant design. The study will provide information on implant survival and soft tissue and bone maintenance as clinical performance of the OsseoSpeedTM TX Profile Implant in the aesthetic zone or the posterior mandible with socket like atrophy.

Read the detailed description

Within the new OsseoSpeedTM TX Profile Implant from Astra Tech a special surface modification treated with diluted hydrofluoric acid is combined with an inclined implant-abutment interface to support soft tissue and marginal bone maintenance in the aesthetic zone or the socket like atrophy in the mandible. Pre-clinical studies of the OsseospeedTM modification support improvement in osseointegration. Both aspects are of special clinical interest in critical situations e.g. reduced bone quantity and quality or in case of socket atrophy with loss of the papillae. The outcome variables of interest are implant survival and the marginal bone and soft tissue response for clinical evaluation of the OsseoSpeedTM TX Profile Implant from Astra Tech. In contrast to the original treatment protocol with a healing period of 3 and 6 months for maxilla and mandible, respectively, the healing period is reduced to 3 months following the recent literature with equal clinical results. Within the present study implants will heal in a transgingival mode and loaded after a healing period of 3 months. For special indications in the aesthetic zone the implants may optionally be loaded following an early loading protocol, which comprehend temporary loading within 48h after implant insertion. Overall implant survival rates are high. However, for implants placed immediately after tooth extraction in the esthetic zone or in the socket like atrophied mandible survival rates are lower. The special physiology of bone resorption in the aesthetic zone exhibit high requirements for soft tissue and bone maintenance for good clinical long term results. Differences in pattern of marginal bone response have been described for different implant systems. The extend of bone loss as also the pattern of remodeling as reaction to OsseospeedTM surface and the special shape of the OsseoSpeedTM TX Profile Implant will be investigated within the present study.

Keywords
dental implant, soft tissue maintenance, bone remodelling, inclined atrophy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01400321
Study groupRoleWhat they receive
Distal regionPatients with loss of tooth in the premolar and molar region of the atrophied mandible
aesthetic zonePatients with loss of tooth within the aesthetic zone (canine to canine)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Implant survival

    How many implants are in situ after an observational period of 24 months (2 years). Data presentation will be a Kaplan Meier Estimate.

    Measured: after 24 months

Secondary outcomes (4)
  1. Marginal bone adaption

    Marginal bone adaptation will be assessed clinically as probing depth on the lingual aspect of insertion. In addition marginal bone adaption will be followed as the distance from the implant reference point to the most coronal bone-to-implant contact on the mesial and distal side of the implant on intraoral radiographs with paralleling technique. Periapical radiographs will be taken pre- and postoperatively at 24 months follow-up visit. A change in marginal bone will be recorded as positive or negative shift compared to the baseline (preoperatively measured bone height).

    Measured: after 24 months

  2. Pinc aesthetic parameter

    Pinc aesthetic score evaluation as previously described by Fürhauser and measurement of width of keratinized mucosa and clinical crone length. Data evaluation will be a negative or positive shift compared to the preoperatively evaluated data.

    Measured: after 24 months

  3. periodontal parameter

    Clinical evaluation of of probing depth in mm (mesial, distal, oral and vestibular), bleeding on probing and Plaque Index as described by Sillness and Löe. Data evaluation will be a negative or positive shift compared to the preoperatively evaluated data.

    Measured: after 24 months

  4. Detection and description of implant related complications and other adverse and serious adverse events

    Complications are characterized by any failure (mechanical or other) of the implant and/or the prosthetic restoration, as well as the treatment of such failures and will be recorded. The following complications must be reported to the Principal Investigator within 4 working days:

    • Failed osseointegration
    • Lost osseointegration
    • Fixture fracture Adverse events and serious adverse events detection and reporting following GCP-ICH

    Measured: over the study period (24 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jul 2011 (estimated)
  2. Study startJul 2011
  3. Primary completionJul 2014 (estimated)
  4. Study completionJul 2014 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01400321
Sponsor's protocol ID
GAST
Acronym
GAST
Status last verified
Nov 2012
First submitted
7 Jun 2011
Last updated
16 Nov 2012
Results posted
No
Data monitoring committee
No

Publications

  • Schiegnitz E, Noelken R, Moergel M, Berres M, Wagner W. Survival and tissue maintenance of an implant with a sloped configurated shoulder in the posterior mandible-a prospective multicenter study. Clin Oral Implants Res. 2017 Jun;28(6):721-726. doi: 10.1111/clr.12869. Epub 2016 May 13.

    PubMed 27172991

Questions about this trial

What is this clinical trial studying?

An observational study of Inclined Atrophy of the Distal Mandible and Socket Like Atrophy of the Aesthetic Zone, run by Johannes Gutenberg University Mainz at 28 sites in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Nov 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 28 sites in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Wilfried Wagner, MD, DMD, PHD (00496131177334, wilfried.wagner@unimedizin-mainz.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Implant survival (time frame: after 24 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01400321, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Nov 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in